Literature DB >> 2643040

Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.

K Arahata1, T Ishihara, K Kamakura, T Tsukahara, S Ishiura, C Baba, T Matsumoto, I Nonaka, H Sugita.   

Abstract

A deficiency of the protein dystrophin is known to be the cause of Duchenne's muscular dystrophy. To examine the expression of dystrophin in symptomatic female carriers of this X-linked recessive disorder, we performed immunohistochemical studies on muscle-biopsy specimens from three such carriers, using an antiserum raised against a synthetic peptide fragment of dystrophin. In all three carriers, most individual muscle fibers reacted either strongly or not at all to the antiserum for dystrophin; only 2 to 8 percent of fibers showed partial immunostaining. This mosaic staining pattern was present on both cross-sectional and longitudinal muscle specimens. Although the mosaic pattern was seen in all fiber types, more than 80 percent of type 2B and 2C fibers from two of the carriers did not react with the antiserum. Similar studies in nine normal subjects showed consistently strong staining of all muscle fibers. No muscle fibers from 31 patients with Duchenne's muscular dystrophy reacted with the antiserum. We conclude that symptomatic carriers of Duchenne's muscular dystrophy can be identified by a distinct mosaic pattern in the immunohistochemical staining of the surface membrane of skeletal-muscle specimens. This finding may have practical implications for genetic counseling, although it remains to be shown whether the same staining pattern will be found in muscle specimens from asymptomatic carriers of Duchenne's muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643040     DOI: 10.1056/NEJM198901193200302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

Review 1.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Duchenne muscular dystrophy: evidence for somatic reversion of the mutation in man.

Authors:  R Gold; B Meurers; H Reichmann; W Kress; C R Müller
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

3.  A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms.

Authors:  K Kamakura; M Kawai; K Arahata; H Koizumi; K Watanabe; H Sugita
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

4.  A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.

Authors:  M Vainzof; M R Passos-Bueno; R C Pavanello; R Schreiber; M Zatz
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

5.  A first-generation X-inactivation profile of the human X chromosome.

Authors:  L Carrel; A A Cottle; K C Goglin; H F Willard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Heterozygotic gene expression in endomyocardial biopsies: a new diagnostic tool confirms the Duchenne carrier status.

Authors:  M Schmidt-Achert; P Fischer; W Müller-Felber; H Mudra; D Pongratz
Journal:  Clin Investig       Date:  1993-03

7.  Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.

Authors:  E Pegoraro; R N Schimke; K Arahata; Y Hayashi; H Stern; H Marks; M R Glasberg; J E Carroll; J W Taber; H B Wessel
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

8.  Abnormal dystrophin expression in patients with limb girdle syndromes.

Authors:  S Beyenburg; S Zierz; K Arahata; R R Mundegar; W Friedl; F Jerusalem
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

9.  Immunohistochemical studies show truncated dystrophins in the myotubes of three fetuses at risk for Duchenne muscular dystrophy.

Authors:  I B Ginjaar; E Bakker; M M van Paassen; J T den Dunnen; A Wessels; E E Zubrzycka-Gaarn; A F Moorman; G J van Ommen
Journal:  J Med Genet       Date:  1991-08       Impact factor: 6.318

10.  Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice.

Authors:  Yongping Yue; Jeffrey W Skimming; Mingju Liu; Tammy Strawn; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2004-06-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.